Pharma Marketing Network

OCTOBER 28, 2023

It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients. What is Patient-Centricity?

Pharma Companies 52

Pharma Companies Marketing Development Sales 52

pharmaphorum

JULY 15, 2021

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS. The regulator says that the in addition to the fines, the NHS may choose to pursue the companies for damages in the courts.

Marketing 119

Marketing Sales Pharma Companies Medicine 119

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Dermatology 97

Dermatology Production Pharma Companies Marketing 97

Pharma Marketing Network

SEPTEMBER 14, 2020

The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. The video creation ideas below can be immediately executed and could potentially make a huge difference for your sales team and between your reps and HCPs. HCP Patient Education.

Sales 105

Sales Pharma Companies Nurses Compliance 105

pharmaphorum

NOVEMBER 30, 2022

The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharma company (i.e.

Life Science 90

Life Science Pharma Companies Sales Marketing 90

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. But what steps can the smaller companies at the cutting edge take to make them acquisition-ready and maximise their value during this process?

Compliance 107

Compliance Regulation Manufacturing Licensing 107

pharmaphorum

APRIL 27, 2022

This is particularly evident in marketing. Instead, companies are increasingly turning to omnichannel marketing to bridge gaps in communication created by the pandemic. In previous years, pharma was largely in charge of the marketing experience, sending reps to meet with customers face-to-face.

Marketing 116

Marketing Sales Production Development 116

Camargo

NOVEMBER 11, 2020

When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.

Development 242

Development Bioequivalency Generic Drugs Production 242

pharmaphorum

JUNE 2, 2022

This is why the action by the US in 1983 and subsequently the European Commission Regulation No. 141/2000 (the Orphan Regulation), that both acted to encourage development in the area, are regarded as crucial for changing the landscape in rare disease R&D. The price is right. Raising questions.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

FEBRUARY 14, 2022

The easy answer as to why this has happened can be quickly linked to the COVID-19 pandemic, where sales of vaccines and treatments led to a large increase in return on investment and sales projections. As a result, the estimated peak sales of assets increased from $360 million to $521 million in 2019 and 2021, respectively.

Production 92

Production Clinical Trials Clinical Trials Sales 92

pharmaphorum

JUNE 20, 2022

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan drug market and forecasts what the future of the industry holds based on data. Revising legislation. Positive projections.

Drugs 52

Drugs Marketing Life Science Regulation 52

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 195

Manufacturing Marketing Pharma Companies Vaccination 195

XTalks

MARCH 28, 2024

Bettica said the company’s focus is to now “make Duvyzat available as a treatment for DMD management in the US as quickly as possible.” In November, the FDA extended its decision deadline by three months to allow extra time for regulators to review additional information submitted by Italfarmaco as part of a new drug application.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

Pharma Marketing Network

SEPTEMBER 14, 2020

The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. The video creation ideas below can be immediately executed and could potentially make a huge difference for your sales team and between your reps and HCPs. HCP Patient Education.

Sales 69

Sales Pharma Companies Nurses Compliance 69

pharmaphorum

JANUARY 6, 2021

The regulator said it wanted more long-term safety and efficacy data from the REGENERATE study before making a final decision on the drug, which had been expected to be the first entrant into a likely multi-billion dollar market niche. billion annually if approved.

Gene Silencing 52

Gene Silencing Regulation Pharma Companies Doctors 52

pharmaphorum

JANUARY 26, 2023

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time. It has drawn up the guidance with the help of the companies, the ABPI, and UK regulator the MHRA.

Medicine 96

Medicine Pharma Companies Clinical Trials Clinical Trials 96

pharmaphorum

MAY 25, 2022

The move to online international meetings has left pharma companies with uncertainty around contact compliance. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity.

Regulation 97

Regulation Compliance Manufacturing Medicine 97

pharmaphorum

MAY 14, 2021

This article appears in our digital magazine, Deep Dive: Market Access 2021. Long headquartered in London, the EU drug regulator is now severed from the country both physically and systematically, with its base now in Amsterdam and the UK now assessing drugs through its own regulatory agency, MHRA.

Marketing 59

Marketing Regulation Medicine Life Science 59

pharmaphorum

AUGUST 10, 2021

The investment firm said its 155p offer was “full and fair” and would not be raised, meaning that it would not enter into a head-to-head auction demanded by the UK’s Takeover Panel, which regulates mergers and acquisitions involving UK registered companies. PMI buys OtiTopic.

Regulation 52

Regulation FDA Approval Pharma Companies Marketing 52

pharmaphorum

APRIL 28, 2022

Although they have, by definition, small addressable markets, the treatments cost just as many resources to develop as therapies for more common diseases – sometimes more, because of the added difficulty of finding sufficiently large patient populations for trials and finding disease experts to run them. So that is the trick.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

pharmaphorum

NOVEMBER 23, 2022

Innovative offerings around market access. A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My I’ve always worked as a consultant for pricing and access strategies for clients, helping them to get drugs to market and access patients.

Life Science 95

Life Science Marketing Medicine Production 95

Creogenic Pharma

APRIL 15, 2023

1* Pharma Franchise Company Submit Lowest Price 250+ Products Best Service Best Quality Products that fall under Gastro segment come under the category of PPIs or Proton Pump Inhibitors. Such category of products regulates the level of stomach acids and help to provide relief against indigestion and burns.

Production 40

Production Manufacturing Pharma Companies Doctors 40

Intouch Solutions

APRIL 11, 2024

Precision engagement is a data-driven approach developed for marketing and sales needs. In the pharma industry, precision engagement can be used to present patients, healthcare professionals (HCPs), and other stakeholders with relevant information and support at the right time. So, what is precision engagement?

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

XTalks

DECEMBER 29, 2022

This highlights potentially new marketing trends that life science companies may have to start looking into if they haven’t already. In 2022 alone, the US regulator approved four new gene therapies, showing the high interest in getting these therapies to market. 4. Social Media Marketing.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

pharmaphorum

JANUARY 26, 2021

As study enrolment continues to lag drastically behind target, patient recruitment is set to rely even more on digital marketing to improve its speed and accuracy. Life sciences companies need to rethink their customer engagement paradigms in light of changing customer preferences. Clinical trials get more and more digitalised.

Clinical Trials 134

Clinical Trials Clinical Trials Sales Life Science 134

Drug Discovery World

MARCH 29, 2023

Regulatory data protection (RDP) period RDP refers to the time when generic drug makers cannot refer to an innovator drug’s data to obtain a marketing authorisation 2. According to EFPIA, RDP protects an innovator’s investment by granting a limited period of exclusivity on the data it generated, starting from marketing authorisation 4.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

pharmaphorum

OCTOBER 7, 2021

Rewind to March of 2020, and pharma companies were facing a communication crisis. Thankfully, many pharma companies had already started on a journey towards digital engagement, and healthcare professionals (HCPs) are embracing the medium more than ever before, thanks in part to newer generations who are increasingly digitally-savvy.

Pharma Companies 89

Pharma Companies Production Clinical Trials Clinical Trials 89

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. Developing market specialist Dr Zulf Masters OBE takes us through the nuances of being successful in this region.

Marketing 82

Marketing Regulation Production Medicine 82

pharmaphorum

OCTOBER 19, 2022

Hyland says Veeva considers these points and other essential factors while helping companies transition to modular content. Because there are numerous components and different stakeholders and teams involved in creating, reviewing, and distributing content in large corporations, especially in pharma, these processes need to be streamlined.

Life Science 78

Life Science Compliance Production Pharma Companies 78

pharmaphorum

DECEMBER 16, 2022

There are already rules that dictate how countries should react against public health events that have the potential to traverse country borders, through the International Health Regulations. The industry has so far resisted demands for the sharing of intellectual property (IP) around products developed to counter the pandemic.

Vaccination 75

Vaccination Vaccine Production Licensing 75

pharmaphorum

OCTOBER 3, 2022

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses. About the author.

Branding 109

Branding Doctors Doctor Compliance 109

pharmaphorum

APRIL 7, 2021

Under the leadership of CEO Jan van de Winkel it has gone from financially precarious position following the stock market crash in the late noughties, to the darling of the Nasdaq with a US IPO of more than $500 million in 2019. Richard Staines is the news editor for pharmaphorum and has been covering the pharma industry since 2010.

Antibody 66

Antibody Life Science Development Regulation 66

Delveinsight

AUGUST 25, 2021

Pharmaceutical companies may deal in both generic and brand-name drugs as well as medical devices. They are governed by a number of rules and regulations that govern drug patenting, testing, safety, efficacy, and marketing. . They both made a sale of USD 3.8 The annual sale of Novartis in the year 2020 was USD 48.6

Vaccination 98

Vaccination Vaccine Sales Drugs 98

Delveinsight

SEPTEMBER 8, 2021

There are several challenges faced by any company entering or persisting in the market, few of which are managerial, statistical, financial, and analytical decisions to be made by a client organization for which they would require people possessing more knowledge in the specified field that can serve as an advantage.

Marketing 52

Marketing Production Sales Life Science 52

pharmaphorum

FEBRUARY 16, 2021

COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. . The R&D focus began to shift, and so did the marketing.

Marketing 91

Marketing Big Data Production Pharma Companies 91

Pharmaceutical Technology

JULY 4, 2022

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

Pharma Production 305

Pharma Production Production Clinical Trials Clinical Trials 305

pharmaphorum

DECEMBER 16, 2020

We’ve also seen a very mixed picture in the market for pharmaceuticals,” he says. Globally, we’ve seen a level of collaboration between companies that we’ve never seen before when it comes to sharing data, technology and evidence – and we’re seeing that on a more local level too. A collaborative future.

Vaccination 121

Vaccination Vaccine Life Science In-Vitro 121